AV-001 for Hospitalized Patients With COVID-19 Disease
Richard Lee
- OPEN TO ACCRUAL
trials found matching your search:
Displaying 3 of 3 Results
A randomised, double-blinded, placebo-controlled, parallel-group phase III trial (REPAVID-22)
Timmy Cheng
- OPEN TO ACCRUAL
University of California COVID-19 and Cancer Registry and Outcomes Project
Warren A Chow
- OPEN TO ACCRUAL